We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+21.84%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$6.11B
AUM Growth
-$283M
Cap. Flow
-$874M
Cap. Flow %
-14.3%
Top 10 Hldgs %
62.65%
Holding
207
New
52
Increased
29
Reduced
48
Closed
56

Top Buys

Rank Stock Value
1
AMTD
TD Ameritrade Holding Corp
AMTD
+$221M
2
TIF
Tiffany & Co.
TIF
+$170M
3
PCG icon
PG&E
PCG
+$105M
4
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$92.5M
5
BA icon
Boeing
BA
+$91.4M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$615M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$363M
3
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$204M
4
WCG
Wellcare Health Plans, Inc.
WCG
+$122M
5
ADSW
Advanced Disposal Services Inc
ADSW
+$77.1M

Sector Composition

Rank Sector Weight
1 Technology 8.69%
2 Financials 4.76%
3 Healthcare 4.33%
4 Utilities 3.73%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDLA
101
DELISTED
Medallia, Inc.
MDLA
$933K 0.02%
30,000
– –
EXAS
102
DELISTED
Exact Sciences
EXAS
$925K 0.02%
10,000
-19,000
-66% -$1.67M
EXAS
103
PUT
DELISTED
Exact Sciences
EXAS
$925K 0.02%
10,000
-170,000
-94% -$14.9M
TMUS icon
104
T-Mobile US
TMUS
$191B
$902K 0.01%
+11,500
New +$905K
ESPR
105
CALL
DELISTED
Esperion Therapeutics
ESPR
$894K 0.01%
15,000
-140,000
-90% -$6.29M
STRO icon
106
Sutro Biopharma
STRO
$413M
$879K 0.01%
7,989
-919
-10% -$94.7K
SWI
107
DELISTED
SolarWinds Corporation Common Stock
SWI
$871K 0.01%
44,515
-2,885
-6% -$57.2K
CLVT icon
108
Clarivate
CLVT
$1.19B
$840K 0.01%
+50,000
New +$842K
WORK
109
DELISTED
Slack Technologies, Inc.
WORK
$787K 0.01%
35,000
+5,000
+17% +$111K
GMAB icon
110
Genmab
GMAB
$19.3B
$782K 0.01%
35,000
-1,500
-4% -$32.7K
DUK icon
111
Duke Energy
DUK
$95.6B
$730K 0.01%
+8,000
New +$733K
PING
112
DELISTED
Ping Identity Holding Corp.
PING
$729K 0.01%
30,000
-8,000
-21% -$153K
NNA
113
DELISTED
Navios Maritime Acquisition Corporation
NNA
$723K 0.01%
+85,000
New +$675K
TELA icon
114
TELA Bio
TELA
$39.3M
$689K 0.01%
+53,239
New +$651K
MRNA icon
115
Moderna
MRNA
$22.3B
$685K 0.01%
35,000
+18,000
+106% +$319K
PS
116
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$647K 0.01%
37,600
– –
MGP
117
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$619K 0.01%
+20,000
New +$615K
TTEC icon
118
TTEC Holdings
TTEC
$129M
$594K 0.01%
+15,000
New +$657K
HBT icon
119
HBT Financial
HBT
$1.31B
$570K 0.01%
+30,000
New +$511K
SPT icon
120
Sprout Social
SPT
$615M
$562K 0.01%
+35,000
New +$568K
TENB icon
121
Tenable Holdings
TENB
$3.98B
$553K 0.01%
23,100
– –
BILL icon
122
BILL Holdings
BILL
$4.83B
$514K 0.01%
+13,500
New +$513K
MIST icon
123
Milestone Pharmaceuticals
MIST
$148M
$512K 0.01%
32,000
+7,000
+28% +$124K
BCYC
124
Bicycle Therapeutics
BCYC
$286M
$496K 0.01%
52,587
-5,100
-9% -$46.2K
ZUO
125
DELISTED
Zuora, Inc.
ZUO
$473K 0.01%
33,000
– –
3 4
5
6 7

Similar funds

CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Pentwater Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Pentwater Capital Management held 207 positions worth $6.11B, down 4.4% from $6.4B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Pentwater Capital Management withdrew a net $874M in Q4 2019, closing 56 positions and reducing 48 holdings. Its most notable exit was Celgene Corp, an estimated $615M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Pentwater Capital Management opened a new position in TD Ameritrade Holding Corp worth $253M.

  • Pentwater Capital Management's largest Q4 2019 buy was TD Ameritrade Holding Corp: 5,089,000 shares worth $253M.
  • Pentwater Capital Management added most to PG&E in Q4 2019, an estimated $105M increase.
  • Pentwater Capital Management's biggest Q4 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $122M.
  • Pentwater Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $615M.
  • Pentwater Capital Management's ten largest holdings make up 63% of its $6.11B portfolio in Q4 2019.
  • Pentwater Capital Management opened 52 new positions and closed 56 in Q4 2019.
  • Pentwater Capital Management's portfolio value fell 4.4% quarter-over-quarter to $6.11B.

Based on Pentwater Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.